Mediplantex National Pharmaceutical JSC (HNX:MED)

Market Cap	253.16B +55.0%
Revenue (ttm)	367.08B -17.2%
Net Income	15.27B +0.2%
EPS	1,231.00 +0.2%
Shares Out	12.41M
PE Ratio	16.57
Forward PE	n/a
Dividend	900.00 (3.60%)
Ex-Dividend Date	Jul 16, 2025

Volume	100
Average Volume	2,738
Open	20,400
Previous Close	n/a
Day's Range	20,400 - 20,400
52-Week Range	20,400 - 28,600
Beta	0.13
RSI	35.61
Earnings Date	Feb 3, 2026

About HNX:MED

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam and internationally. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and ex...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 328
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MED

Financial Performance

In 2025, HNX:MED's revenue was 367.08 billion, a decrease of -17.16% compared to the previous year's 443.14 billion. Earnings were 15.27 billion, an increase of 0.16%.